Revelation Biosciences In... (REVB)
NASDAQ: REVB
· Real-Time Price · USD
0.85
-0.03 (-3.41%)
At close: May 30, 2025, 3:59 PM
0.84
-1.18%
After-hours: May 30, 2025, 05:55 PM EDT
-3.41% (1D)
| Bid | 0.83 |
| Market Cap | 1.8M |
| Revenue (ttm) | 26.96K |
| Net Income (ttm) | -14.41M |
| EPS (ttm) | -37.42 |
| PE Ratio (ttm) | -0.02 |
| Forward PE | -0.67 |
| Analyst | n/a |
| Ask | 0.86 |
| Volume | 467,081 |
| Avg. Volume (20D) | 158,953 |
| Open | 0.90 |
| Previous Close | 0.88 |
| Day's Range | 0.84 - 0.90 |
| 52-Week Range | 0.83 - 60.80 |
| Beta | 0.19 |
About REVB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol REVB
Website n/a
2 days ago
-54.4%
Revelation Biosciences shares are trading lower af...
Unlock content with
Pro Subscription
4 months ago
-23.84%
Revelation Biosciences shares are trading lower after the company announced plans for a 1-for-16 reverse stock split.
2 months ago · businesswire.com
Gemini Priming Attenuates Inflammation in Human Peripheral Blood Mononuclear CellsSAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...
2 months ago · businesswire.com
Revelation Biosciences to Host Fireside Chat at 37th Annual Roth ConferenceSAN DIEGO--(BUSINESS WIRE)---- $REVB #AKI--Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on rebalancing inflammati...
